Saurabh Sinha received his Ph.D. in Computer Science from the University of Washington, Seattle, in 2002, and after post-doctoral work at the Rockefeller University with Eric Siggia, he joined the faculty of the University of Illinois, Urbana-Champaign, in 2005, where he held the positions of Founder Professor in Computer Science and Director of Computational Genomics in the Carl R. Woese Institute for Genomic Biology until 2022. He joined Georgia Institute of Technology in 2022, as Wallace H. Coulter Distinguished Chair in Biomedical Engineering, with joint appointments in Biomedical Engineering and Industrial & Systems Engineering. Sinha’s research is in the area of bioinformatics, with a focus on regulatory genomics and systems biology. Sinha is an NSF CAREER award recipient and has been funded by NIH, NSF and USDA. He co-directed an NIH BD2K Center of Excellence and was a thrust lead in the NSF AI Institute at UIUC. He led the educational program of the Mayo Clinic-University of Illinois Alliance, and co-led data science education for the Carle Illinois College of Medicine. Sinha has served as Program co-Chair of the annual RECOMB Regulatory and Systems Genomics conference and served on the Board of Directors for the International Society for Computational Biology (2018-2021). He was a recipient of the University Scholar award of the University of Illinois, and selected as a Fellow of the AIMBE in 2018.

Sakis Mantalaris is currently Professor in Biomedical Engineering at Georgia Tech & Emory. Prior he was Professor in Chemical Engineering at Imperial College London. His expertise is in modelling of biological systems and bioprocesses with a focus on mammalian cell culture systems, stem cell bioprocessing, and tissue engineering. He has received several awards: the Junior Moulton Award for best paper by the IChemE (2004), Fellow of AIMBE (2012), an ERC Advanced Investigator Award (2013), and the Donald Medal by the IChemE for his contributions to biochemical engineering (2015).
 

David’s varied interests have fueled an unusual educational background that fuses engineering, microsystem design, biology, and clinical research. David received his PhD in mechanical engineering from the University of California at Berkeley, under the tutelage of one of the early microsystems pioneers, Albert P. Pisano, PhD. Driven by a desire to see new types of sensors in the clinic, David undertook a postdoctoral fellowship in biomedical and clinical research with Wilbur A. Lam, MD, PhD, in the Wallace H. Coulter Department of Biomedical Engineering at Emory University and the Georgia Institute of Technology. Working at the intersection of these fields, David has authored or contributed to publications in Nature Materials, Nature Communications, PNAS, and Blood. 

My lab, Biohybrid System Laboratory, is interested in elucidating how biological systems coordinate the hierarchical structures and functions of their individual components, in order to produce emergent physical behaviors, and how disrupting this coordination potentiates disease. We seek to design, build, and test a hierarchy of biohybrid systems capable of reproducing the targeted behaviors. Our primary interest is coordinated activation and contraction of tissue- and organ-level cardiac and skeletal muscle systems. To pursue this goal, we focus on the development of biohybrid fabrication methods and measurement systems through the combined application of genetic tools, induced pluripotent stem cells, tissue engineering, microfabrication, electronics, optics, and feedback control. The resulting findings and technical developments will be translated into various applications such as (1) stem cell-based functional assays for personalized disease diagnosis and treatment and (2) new types of biohybrid actuators for creating biological autonomous systems.

Dr. Leslie Chan is an Assistant Professor in the Wallace H. Coulter Department of Biomedical Engineering at the Georgia Tech School of Engineering and Emory School of Medicine. Her research program integrates core and emerging principles from drug delivery, biomaterials development, and chemical biology to engineer diagnostic and therapeutic solutions for infectious disease, microbiome dysbiosis, and inflammatory diseases. Dr. Chan earned her B.S. in Biomedical Engineering from Georgia Tech and her Ph.D. in Bioengineering from the University of Washington with Professor Suzie Pun. She completed her postdoctoral training at Massachusetts Institute of Technology with Professor Sangeeta Bhatia. Dr. Chan is the recipient of an NIH K99/R00 Pathway to Independence Award.

Eberhard Voit’s research interests are in the area of complex biomedical systems. Work in his lab focuses on genomic, metabolic, and signaling systems with applications reaching from microbial and plant systems to human diseases. Voit has authored or co-authored about two hundred fifty scientific articles and book chapters as well as several books. Voit is an elected a fellow in the American Institute for Medical and Biological Engineering (AIMBE) and the American Association for the Advancement of Science (AAAS).

Denis Tsygankov, PhD, is Assistant Professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech School of Engineering and Emory University School of Medicine. 

Dr. Tsygankov is interested in developing and applying computational methods, including mathematical modeling, simulations, and computer vision approaches to understand complex multi-scale physiological processes including vasculogenesis, morphogenesis, and cancer. 

He is a member of the Cell and Molecular Biology Research Program at Winship Cancer Institute.

Dr. Johnna S. Temenoff is the Carol Ann and David D. Flanagan Professor at the Coulter Department of Biomedical Engineering at Georgia Tech/Emory University. She is also currently the Director of the NSF Engineering Research Center in Cell Manufacturing Technologies (CMaT) and the Director of the Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M). Scientifically, Dr. Temenoff is interested in scaling culture of therapeutic cells and tailoring the molecular interactions between glycosaminoglycans and proteins/cells for use in regenerative medicine applications.  Her laboratory focuses primarily on promoting repair after injuries to the tissues of the shoulder, including cartilage, tendon, and muscle.

Dr. Temenoff has been honored with several prestigious awards, such as the NSF CAREER Award, Arthritis Foundation Investigator Award, and Society for Biomaterials (SFB) Clemson Award for Contributions to the Literature, and was named to the College of Fellows of the American Institute for Medical and Biological Engineers (AIMBE), as a Fellow of the Biomedical Engineering Society (BMES), as a Fellow of the International Academy of Medical and Biological Engineering (IAMBE) and as a Fellow of Biomaterials Science and Engineering, International Union of Societies for Biomaterials Science and Engineering (IUSBSE).  She has co-authored a highly successful introductory textbook - Biomaterials: The Intersection of Biology and Materials Science, by J.S. Temenoff and A.G. Mikos (now in a 2nd edition), for which Dr. Temenoff and Dr. Mikos were awarded the American Society for Engineering Education’s Meriam/Wiley Distinguished Author Award for best new engineering textbook. 

Garrett Stanley is the McCamish Foundation Distinguished Chair in the Department of Biomedical Engineering at Georgia Tech and Emory University and is the Co-Director of the Georgia Tech Neural Engineering Center. He has formal training, both at undergraduate and doctorate levels, in engineering (specifically trained in Control Theory through all of his graduate work), and has worked extensively in the field of neuroscience, specifically in sensory processing in the brain, and more specifically in vision and somatosensation (touch). 

From 1999 to 2007, he was an Associate Professor in the Division of Engineering & Applied Sciences at Harvard University, where he was the leader of the Harvard Biocontrols Laboratory. Professor Stanley is now a faculty member in the Department of Biomedical Engineering at Georgia Tech/Emory University (2008-2013 Associate Professor, 2014-present Full Professor), and leads several programmatic efforts at the interface between basic neuroscience and neurotechnology (Co-Direct the GT Neural Engineering Center, Direct Computational Neuroscience training program, Director of Graduate Studies, etc.). In terms of research, he is the leader of the Neural Coding group in the Laboratory for Neuroengineering. 

The research of his group has been funded by the National Institute of Health, National Science Foundation, the Office of Naval Research, DARPA, and several private foundations. Prof. Stanley’s group routinely publishes our research in the top Neuroscience journals, along with more technical work in engineering journals. He is considered a leader in the field nationally and internationally.

The central goal of Dr. Singer’s research program is to understand how neural activity produces memories and spurs the brain’s immune system. Dr. Singer’s research integrates innovative behavioral, electrophysiological, and computational methods to identify and restore failures in neural activity that lead to memory impairment. Dr. Singer has established and continues to develop a new therapeutic approach to Alzheimer’s disease, novel forms of non-invasive stimulation, and new ways to manipulate the brain’s immune system. Additionally, using non-invasive approaches, she is translating her discoveries from rodents to develop radically new ways to treat diseases that affect memory in humans.